IP Library Granted Patent US 8,241,884
Granted Patent B2
US 8,241,884 · App. 12/469,208 · Granted Aug 14, 2012

Δ17 desaturase and its use in making polyunsaturated fatty acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,241,884
App. No.
12/469,208
Granted
Aug 14, 2012
Kind
B2
Abstract

The present invention relates to Δ17 desaturases, which have the ability to convert ω-6 fatty acids into their ω-3 counterparts (i.e., conversion of arachidonic acid [20:4, ARA] to eicosapentaenoic acid [20:5, EPA]). Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding Δ17 desaturases along with a method of making long-chain polyunsaturated fatty acids (PUFAs) using these Δ17 desaturases in oleaginous yeast are disclosed.

Claims (8)

1. An isolated nucleic acid fragment comprising a nucleic acid sequence encoding a delta-17 desaturase polypeptide comprising SEQ ID NO:97 and three His Box motifs set forth as H(X) 3 H (SEQ ID NO:99), H(X) 2 HH (SEQ ID NO:100) and H/Q(X) 2 HH (SEQ ID NO:101); wherein:

(i) the delta-17 desaturase polypeptide does not have anmino acid sequence selected from the group consisting of:

(a) SEQ ID NO:43;

(b) SEQ ID NO:95; and,

(ii) the delta-17 desaturase polypeptide is capable of converting a polyunsaturated fatty acid substrate, selected from the group consisting of dihomo-γ-linolenic acid and arachidonic acid, to a polyunsaturated fatty acid product, wherein the dihomo-γ-linolenic acid is converted to eicosatetraenoic acid and the arachidonic acid is converted to eicosapentaenoic acid;

and further wherein said isolated nucleic acid fragment comprising a nucleic acid sequence encoding a delta-17 desaturase polypeptide is obtained by a method comprising:

a) identifying a desaturase polypeptide comprising the His Box motifs set forth as H(X) 3 H (SEQ ID NO:99), H(X) 2 HH (SEQ ID NO:100) and H/Q(X) 2 HH (SEQ ID NO:101); and,

b) confirming the presence of SEQ ID NO:97 in the desaturase polypeptide of step (a), wherein the presence of SEQ ID NO:97 is indicative of delta-17 desaturase activity.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →